期刊文献+

以浸润模式为基础的新的风险分层体系在宫颈HPV相关性腺癌中的应用 被引量:2

Application of a new risk stratification system based on infiltration pattern in cervical HPV related adenocarcinoma
下载PDF
导出
摘要 目的:探讨以浸润模式为基础的新的风险分层体系在宫颈HPV相关性腺癌中的应用及临床意义。方法:收集首都医科大学附属北京妇产医院2016年6月至2019年11月诊断的宫颈腺癌病例。经过筛选,共入组54例HPV相关性腺癌。采用以Silva分型为基础的新的风险分层体系,将54例HPV相关性腺癌分为Pattern A、Pattern B和Pattern C三种亚型,并分析各亚型的临床病理特征。结果:在54例宫颈HPV相关性腺癌中,Pattern A 17例(31.5%),Pattern B 10例(18.5%),Pattern C 27例(50.0%)。17例Patter n A均为I期,所有病例未见淋巴管脉管间隙浸润(lymphatic vascular space invasion,LVSI)及淋巴结转移,10例Pattern B均为Ⅰ期,1例可见LVSI,所有病例未见淋巴结转移。27例Pattern C包括Ⅰ期15例、Ⅱ期6例、Ⅲ期6例,10例(37.0%)可见LVSI,6例伴有淋巴结转移。54例HPVA患者的FIGO分期与各Pattern分型的差异具有统计学意义(χ^(2)=15.172,P<0.001)。在浸润深度方面,Pattern A和Pattern C的差异有统计学意义(χ^(2)=9.279,P=0.005)。在LVSI方面,Pattern A和Pattern C的差异有统计学意义(χ^(2)=17.443,P<0.001)。在淋巴结转移率方面,Pattern A和Pattern C的差异有统计学意义(χ^(2)=10.004,P=0.002)。结论:以浸润模式为基础的新的风险分层体系应用到HPVA的病理诊断中,提高了早期HPVA诊断的一致性,可以很好地分流早期HPVA患者。Pattern A很少有淋巴结转移,可以采取更加保守的治疗,免于盆腔淋巴结清扫术,提高生活质量。Pattern C需要采取更加积极的治疗。Pattern B的治疗选择还需更进一步的研究。与FIGO分期相比,以浸润模式为基础的新的风险分层体系,能够更加个体化地指导HPV,尤其是Pattern A相关性腺癌患者的治疗。 Objective:To explore the application and clinical significance of a new risk stratification system based on infiltration pattern in cervical HPV related adenocarcinoma.Methods:Cases of cervical adenocarcinoma diagnosed in Beijing Obstetrics and Gynecology Hospital,Capital Medical University from June 2016 to November 2019 were collected.After screening,54 patients with HPV related adenocarcinoma were enrolled.According to a new risk stratification system based on the Silva classification,the 54 patients with HPV related adenocarcinoma were divided into Pattern A,Pattern B and Pattern C,and their clinicopathological characteristics were analyzed.Results:Among 54 patients with HPV related adenocarcinoma,17 patients were Pattern A(31.5%),10 patients were Pattern B(18.5%),27 patients were Pattern C(50.0%);17 patients with Pattern A were all stage Ⅰ.No lymphatic vascular space infiltration(LVSI)or lymph node metastasis was found in all patients;10 patients with Pattern B were all stage Ⅰ.LVSI was found in 1 patient,and no lymph node metastasis was found in all patients;27 patients with Pattern C included 15 patients in stage Ⅰ,6 patients in stage Ⅱ and 6 patients in stage Ⅲ.LVSI was found in 10 patients(37.0%)and lymph node metastasis in 6 patients.There was significant difference between FIGO stage and pattern typing in 54 patients with HPV related adenocarcinoma(χ^(2)=15.172,P<0.001).In depth of invasion,Pattern A and C were significantly different(χ^(2)=9.279,P=0.005).In LVSI,the difference between Pattern A and C was statistically significant(χ^(2)=17.443,P<0.001).In lymph node metastasis rate,Pattern A and Pattern C were significantly different(χ^(2)=10.004,P=0.002).Conclusion:The new risk stratification system based on infiltration model can be applied to the pathological diagnosis of HPV related adenocarcinoma,improve the consistency of early diagnosis of HPV related adenocarcinoma,and can well shunt early HPV related adenocarcinoma patients.Pattern A has little lymph node metastasis,so it can take more conservative treatment,avoid pelvic lymphadenectomy,and improve the quality of life.Pattern C needs to be treated more actively.The treatment choice of Pattern B needs further study.In general,compared with FIGO stage,especially Pattern A,the new risk stratification system based on infiltration pattern can be more individualized to guide the treatment of HPV related adenocarcinoma patients.
作者 王志强 何春燕 张宽根 张晶 詹阳 支文雪 于海云 金玉兰 WANG Zhiqiang;HE Chunyan;ZHANG Kuangen;ZHANG Jing;ZHAN Yang;ZHI Wenxue;YU Haiyun;JIN Yulan(Department of Pathology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100006,China)
出处 《临床与病理杂志》 CAS 2022年第2期411-420,共10页 Journal of Clinical and Pathological Research
关键词 宫颈肿瘤 腺癌 HPV Pattern分型 临床意义 cervical cancer adenocarcinoma HPV pattern typing clinical significance
  • 相关文献

参考文献6

二级参考文献21

  • 1Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
  • 2Charlton M, Chioreso C, Pagedar N. Treatment selection in advanced oropharyngeal cancer: a surveillance, epidemiologyand end results (SEER) patterns of care (POC) analysis[J]. Annals Epidemiol, 2015, 25(9): 704-705.
  • 3Zhang S, Cui X. WHO/ICO information centre on HPV and cervical cancer:un nuevo reeurso en la Web[J]. Fmc Formacibn M6diea Continuada En Atenci6n, 2009, 16(9): 55-57.
  • 4Quick KD, de Koning MN, van DoornL J, et al. HPV genotping and HPV-16 variant analysis in glandular and squamous neoplastic leaions of the uterine cervix[J]. Gynecol Oncol, 2010, 117(2):297-301.
  • 5Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of tumors of female reproductive organs[M]. Lyon: International Agency for Research on Cancer, 2014: 176-178.
  • 6Yu MC, Austin RM, Liu J, etal. The role of high-risk human papilloma virus testing in the surveillance of cervical cancer after treatment [J]. Arch Pathol Lab Med, 2015, 139 (11) : 1437-1440.
  • 7An HJ, Kim KR, Kim IS, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study[J]. Mod pathol, 2005, 18(4): 528-534.
  • 8Miller RA, Mody DR, Tams KC, et al. Glandular lesions of the cervix in clinical practice[J]. Arch Pathol Lab Med, 2015, 139(11): 1431 -1436.
  • 9Mark S, Nicolas W, SholomW, et al. Human papillomavirus testing in the prevention of cervical cancer[J]. Natl Cancer Inst, 2011, 103(5): 368-383.
  • 10Young RH, SeulIyRE. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases [J]. Cancer ,1989, 63(9): 1773-1779.

共引文献235

同被引文献11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部